Education
About Us
Working with TipRanks
Follow Us
KNC Laboratories Co.,Ltd. (JP:6568)
:6568
RESEARCH TOOLSreports
Total Valuation
KNC Laboratories Co.,Ltd. has a market cap or net worth of ¥8.44B. The enterprise value is ―.
Market Cap¥8.44B
Enterprise Value―
Share Statistics
KNC Laboratories Co.,Ltd. has 7,779,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,779,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
KNC Laboratories Co.,Ltd.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 3.27%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)3.27%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee37.35M
Profits Per Employee3.37M
Employee Count219
Asset Turnover0.41
Inventory Turnover2.30
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio11.4
PS Ratio0.00
PB Ratio―
Price to Fair Value0.62
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, KNC Laboratories Co.,Ltd. had revenue of 8.18B and earned 737.33M in profits. Earnings per share was 95.42.
Revenue8.18B
Gross Profit2.32B
Operating Income771.86M
Pretax Income927.99M
Net Income737.33M
EBITDA1.83B
Earnings Per Share (EPS)95.42
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
KNC Laboratories Co.,Ltd. pays an annual dividend of ¥33, resulting in a dividend yield of 3.13%
Dividend Per Share¥33
Dividend Yield3.13%
Payout Ratio34.58%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change-13.67%
50-Day Moving Average1.05K
200-Day Moving Average1.08K
Relative Strength Index (RSI)56.68
Average Volume (3m)3.79K
Important Dates
KNC Laboratories Co.,Ltd. upcoming earnings date is Aug 8, 2025, TBA (Confirmed).
Last Earnings DateMay 13, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend DateSep 29, 2025
Financial Position
KNC Laboratories Co.,Ltd. as a current ratio of 3.30, with Debt / Equity ratio of ―
Current Ratio3.30
Quick Ratio2.17
Debt to Market Cap0.37
Net Debt to EBITDA0.40
Interest Coverage Ratio40.21
Taxes
In the past 12 months, KNC Laboratories Co.,Ltd. has paid 190.66M in taxes.
Income Tax190.66M
Effective Tax Rate0.21
Enterprise Valuation
KNC Laboratories Co.,Ltd. EV to EBITDA ratio is 4.99, with an EV/FCF ratio of -5.01.
EV to Sales1.11
EV to EBITDA4.99
EV to Free Cash Flow-5.01
EV to Operating Cash Flow6.13
Balance Sheet
KNC Laboratories Co.,Ltd. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share¥1.75K
Margins
Gross margin is ―, with operating margin of 9.44%, and net profit margin of 9.01%.
Gross Margin―
Operating Margin9.44%
Pretax Margin11.35%
Net Profit Margin9.01%
EBITDA Margin22.33%
EBIT Margin11.58%
Analyst Forecast
The average price target for KNC Laboratories Co.,Ltd. is ¥1,201.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥1,201.00
Price Target Upside10.69% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast-10.66%
EPS Growth Forecast-50.69%